Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-Jul-24 5:41 PM View:  | Schiller Mark C. Chief Legal Officer | Kezar Life Sciences, Inc. (KZR) | 02-Jul-24 | Sale | 6,688 | $0.58 | $3,879.04 | (17%) 39.7K to 33.01K | |
| 17-Aug-23 7:08 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 15-Aug-23 | Gift | 3,500,000 | -- | -- | (64%) 5.45M to 1.95M | |
| 24-Jul-23 4:20 PM View: | Kirk Christopher J. Director | Kezar Life Sciences, Inc. (KZR) | 20-Jul-23 | Option Exercise | 48,950 | $0.90 | $44,055.00 | 13% 382.4K to 431.35K | |
| 07-Feb-23 4:11 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 06-Feb-23 | Sale | 40,000 | $6.88 | $275,320.00 | (< 1%) 5.49M to 5.45M | |
| 07-Feb-23 4:11 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 03-Feb-23 | Sale | 25,000 | $7.15 | $178,650.00 | (< 1%) 5.51M to 5.49M | |
| 03-Feb-23 4:32 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 02-Feb-23 | Sale | 50,000 | $7.19 | $359,500.00 | (< 1%) 5.56M to 5.51M | |
| 03-Feb-23 4:32 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 01-Feb-23 | Sale | 40,000 | $6.95 | $278,000.00 | (< 1%) 5.6M to 5.56M | |
| 01-Feb-23 4:07 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 31-Jan-23 | Sale | 30,000 | $7.08 | $212,400.00 | (< 1%) 5.63M to 5.6M | |
| 01-Feb-23 4:07 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 30-Jan-23 | Sale | 30,000 | $6.91 | $207,300.00 | (< 1%) 5.66M to 5.63M | |
| 27-Jan-23 4:17 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 25-Jan-23 | Sale | 50,000 | $6.85 | $342,500.00 | (< 1%) 5.71M to 5.66M | |
| 25-Jan-23 6:17 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 24-Jan-23 | Sale | 80,000 | $6.98 | $558,400.00 | (1%) 5.79M to 5.71M | |
| 25-Jan-23 6:17 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 23-Jan-23 | Sale | 80,000 | $6.81 | $544,800.00 | (1%) 5.87M to 5.79M | |
| 19-Jan-23 4:12 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 17-Jan-23 | Sale | 6,114 | $6.79 | $41,514.10 | (< 1%) 5.88M to 5.87M | |
| 17-Jan-23 4:28 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 13-Jan-23 | Sale | 1,971 | $7.15 | $14,092.70 | (< 1%) 5.88M to 5.88M | |
| 17-Jan-23 4:28 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 12-Jan-23 | Sale | 5,000 | $6.77 | $33,850.00 | (< 1%) 5.89M to 5.88M | |
| 09-Jan-23 4:08 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 06-Jan-23 | Sale | 3,000 | $6.89 | $20,670.00 | (< 1%) 5.89M to 5.89M | |
| 09-Jan-23 4:08 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 05-Jan-23 | Sale | 12,162 | $6.97 | $84,769.10 | (< 1%) 5.9M to 5.89M | |
| 05-Jan-23 4:10 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 04-Jan-23 | Sale | 30,000 | $7.17 | $215,100.00 | (< 1%) 5.93M to 5.9M | |
| 05-Jan-23 4:10 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 03-Jan-23 | Sale | 500 | $7.10 | $3,550.00 | (< 1%) 5.93M to 5.93M | |
| 05-Jan-23 4:10 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 29-Dec-22 | Sale | 25,000 | $7.10 | $177,500.00 | (< 1%) 5.96M to 5.93M | |
| 14-Nov-22 8:13 AM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 10-Nov-22 | Option Exercise | 27,000 | $0.90 | $24,300.00 | 7% 409.12K to 436.12K | |
| 11-Jan-23 10:00 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 18-Oct-22 | Gift | 120,000 | -- | -- | (2%) 6.05M to 5.93M | |
| 05-Oct-22 4:05 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 04-Oct-22 | Sale | 3,612 | $8.82 | $31,857.50 | (< 1%) 6.08M to 6.08M | |
| 05-Oct-22 4:05 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 03-Oct-22 | Sale | 28,700 | $8.78 | $251,957.00 | (< 1%) 6.11M to 6.08M | |
| 27-Jun-22 6:30 PM View: | Kirk Christopher J. President and CSO Director | Kezar Life Sciences, Inc. (KZR) | 23-Jun-22 | Option Exercise | 33,060 | $0.90 | $29,754.00 | 9% 348.42K to 381.48K | |
| 22-Mar-22 5:45 PM View: | Berger Franklin M Director | Kezar Life Sciences, Inc. (KZR) | 21-Mar-22 | Purchase | 20,000 | $14.77 | $295,400.00 | 2% 870.69K to 890.69K | |
| 22-Mar-22 5:45 PM View: | Berger Franklin M Director | Kezar Life Sciences, Inc. (KZR) | 18-Mar-22 | Purchase | 60,000 | $16.74 | $1,004,400.00 | 7% 810.69K to 870.69K | |
| 05-Jan-22 6:51 PM View: | Kauffman Michael Director | Kezar Life Sciences, Inc. (KZR) | 03-Jan-22 | Market Option Sale (Planned) | 5,000 | $16.45 | $82,250.00 | (7%) 68.69K to 63.69K | |
| 05-Jan-22 6:51 PM View: | Kauffman Michael Director | Kezar Life Sciences, Inc. (KZR) | 03-Jan-22 | Option Exercise | 5,000 | $5.91 | $29,550.00 | 8% 63.69K to 68.69K | |
| 15-Dec-21 6:05 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 14-Dec-21 | Option Exercise | 7,700 | $0.90 | $6,930.00 | 2% 401.42K to 409.12K | |
| 23-Sep-21 10:00 PM View: | Berger Franklin M Director | Kezar Life Sciences, Inc. (KZR) | 22-Sep-21 | Option Exercise | 8,896 | $5.60 | $49,817.60 | 1% 801.79K to 810.69K | |
| 23-Sep-21 10:00 PM View: | Berger Franklin M Director | Kezar Life Sciences, Inc. (KZR) | 21-Sep-21 | Option Exercise | 17,792 | $6.77 | $120,452.00 | 2% 784.0K to 801.79K | |
| 04-Jan-21 8:45 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 31-Dec-20 | Option Exercise | 16,000 | $0.90 | $14,400.00 | 4% 385.42K to 401.42K | |
| 15-Jun-20 4:10 PM View: | Equal Talent Investments Ltd 10% Owner | Kezar Life Sciences, Inc. (KZR) | 11-Jun-20 | Market Purchase | 1,454,540 | $5.50 | $8,000,000.00 | 30% 4.8M to 6.25M | 1% |
| 11-Jun-20 6:29 PM View: | Berger Franklin M Director | Kezar Life Sciences, Inc. (KZR) | 11-Jun-20 | Market Purchase | 100,000 | $5.50 | $550,000.00 | 15% 684.0K to 784.0K | 1% |
| 05-Feb-20 8:21 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase Duplicate | 38,461 | $2.60 | $99,998.60 | 11% 346.95K to 385.42K | |
| 05-Feb-20 8:13 PM View: | Kirk Christopher J. President and CSO Director | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 38,461 | $2.60 | $99,998.60 | 13% 304.15K to 342.61K | |
| 06-Feb-20 4:11 PM View: | Morningside Venture Investm... 10% Owner | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 3,800,000 | $2.60 | $9,880,000.00 | 165% 2.31M to 6.11M | |
| 05-Feb-20 8:17 PM View: | Economides Vassiliki SVP, Strategy & External Aff. | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 5,769 | $2.60 | $14,999.40 | 320% 1.8K to 7.57K | |
| 05-Feb-20 8:19 PM View: | Belsky Marc CFO | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 15,384 | $2.60 | $39,998.40 | 769% 2.0K to 17.38K | |
| 05-Feb-20 8:15 PM View: | Berger Franklin M Director | Kezar Life Sciences, Inc. (KZR) | 04-Feb-20 | Private Purchase | 120,846 | $2.60 | $314,200.00 | 21% 563.16K to 684.0K | |
| 20-Dec-19 4:29 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 19-Dec-19 | Option Exercise | 50,000 | $0.90 | $45,000.00 | 17% 296.95K to 346.95K | |
| 13-Nov-19 7:07 PM View: | Belsky Marc CFO | Kezar Life Sciences, Inc. (KZR) | 13-Nov-19 | Market Purchase | 800 | $2.76 | $2,207.04 | 67% 1.2K to 2.0K | 103% |
| 11-Oct-19 4:24 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 10-Oct-19 | Market Purchase | 1,000 | $3.24 | $3,235.40 | < 1% 295.95K to 296.95K | 73% |
| 21-Aug-19 7:29 PM View: | Economides Vassiliki SVP, Strategy & External Aff. | Kezar Life Sciences, Inc. (KZR) | 20-Aug-19 | Market Purchase | 350 | $4.41 | $1,543.57 | 24% 1.45K to 1.8K | 27% |
| 21-Aug-19 7:38 PM View: | Belsky Marc CFO | Kezar Life Sciences, Inc. (KZR) | 20-Aug-19 | Market Purchase | 200 | $4.42 | $884.00 | 20% 1.0K to 1.2K | 27% |
| 15-Aug-19 7:25 PM View: | Kirk Christopher J. President and CSO Director | Kezar Life Sciences, Inc. (KZR) | 13-Aug-19 | Market Purchase | 5,000 | $4.61 | $23,040.00 | 2% 297.93K to 302.93K | 21% |
| 14-Aug-19 10:00 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 13-Aug-19 | Market Purchase | 2,000 | $4.66 | $9,310.00 | < 1% 293.95K to 295.95K | 20% |
| 12-Aug-19 7:47 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 09-Aug-19 | Market Purchase | 750 | $5.01 | $3,761.02 | < 1% 586.41K to 587.16K | 12% |
| 12-Aug-19 7:47 PM View: | Fowler John Franklin CEO Director | Kezar Life Sciences, Inc. (KZR) | 09-Aug-19 | Market Purchase | 500 | $5.26 | $2,627.50 | < 1% 585.91K to 586.41K | 6% |
